Search

everythinglearnresearchcommunity

for

Search:↓

Men with male pattern baldness have a higher chance of heart disease, especially if they're younger or have severe baldness; no link was found with another type of baldness called alopecia areata.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

Alopecia Areata significantly reduces quality of life, especially in women, long-term sufferers, and severe cases.

Maintaining enough zinc may help prevent and manage hair loss.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

Younger patients with severe alopecia areata often have nail problems.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

Severe alopecia areata may increase the risk of heart-related diseases.

Pulse corticosteroid therapy helps many with severe alopecia areata regrow hair, but has side effects.

Adults and adolescents with severe alopecia areata are willing to take significant health risks for a better chance of hair regrowth.

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

The document concludes that anticonvulsants like phenytoin may cause skin reactions by affecting tryptophan metabolism and suggests researching vitamin levels in patients with drug reactions.

Azathioprine can cause unexpected hair loss and severe bone marrow issues, so careful monitoring is needed.

Using minoxidil and tofacitinib together can effectively treat severe hair loss.

Baricitinib helped regrow hair in patients with severe alopecia areata after other treatments failed.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

Tofacitinib significantly regrows hair in severe alopecia without major side effects.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

New drugs, baricitinib and ritlecitinib, are effective for severe alopecia areata.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

Baricitinib is a promising treatment for severe alopecia areata with minimal side effects.

Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.

People with moderate hair loss from Alopecia Areata feel more impacted than those with no or almost complete hair loss, and are more likely to seek treatment.

Brevilin-A is a safe and effective treatment for mild to moderate alopecia areata in children.

Methotrexate is a promising and safe treatment for severe alopecia areata, with better results when combined with corticosteroids.